Clarius Group LLC’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$940K Sell
13,454
-385
-3% -$26.9K 0.05% 154
2025
Q1
$1.02M Buy
13,839
+3,297
+31% +$242K 0.06% 139
2024
Q4
$691K Buy
10,542
+334
+3% +$21.9K 0.05% 168
2024
Q3
$795K Sell
10,208
-2,962
-22% -$231K 0.06% 145
2024
Q2
$1.03M Sell
13,170
-2,486
-16% -$194K 0.07% 113
2024
Q1
$1.06M Sell
15,656
-1,232
-7% -$83.5K 0.07% 111
2023
Q4
$1.14M Sell
16,888
-420
-2% -$28.3K 0.09% 110
2023
Q3
$1.17M Sell
17,308
-1,517
-8% -$103K 0.11% 100
2023
Q2
$1.35M Buy
18,825
+8
+0% +$573 0.1% 103
2023
Q1
$1.31M Buy
18,817
+326
+2% +$22.6K 0.11% 106
2022
Q4
$1.25M Buy
18,491
+1,846
+11% +$125K 0.11% 111
2022
Q3
$913K Buy
16,645
+1,014
+6% +$55.6K 0.09% 131
2022
Q2
$1.03M Sell
15,631
-119
-0.8% -$7.86K 0.1% 122
2022
Q1
$917K Hold
15,750
0.07% 150
2021
Q4
$917K Buy
15,750
+6,731
+75% +$392K 0.07% 150
2021
Q3
$542K Buy
9,019
+2,904
+47% +$175K 0.05% 200
2021
Q2
$366K Buy
6,115
+386
+7% +$23.1K 0.03% 272
2021
Q1
$285K Sell
5,729
-2,797
-33% -$139K 0.03% 297
2020
Q4
$426K Buy
8,526
+2,433
+40% +$122K 0.05% 195
2020
Q3
$334K Sell
6,093
-66
-1% -$3.62K 0.04% 198
2020
Q2
$326K Buy
6,159
+9
+0.1% +$476 0.05% 201
2020
Q1
$275K Sell
6,150
-45
-0.7% -$2.01K 0.05% 190
2019
Q4
$315K Buy
6,195
+57
+0.9% +$2.9K 0.05% 197
2019
Q3
$274K Buy
+6,138
New +$274K 0.05% 206
2018
Q4
Sell
-6,064
Closed -$240K 120
2018
Q3
$240K Hold
6,064
0.09% 106
2018
Q2
$213K Buy
+6,064
New +$213K 0.09% 81